Luteolin 7-O-glucuronide

Overview

Luteolin 7-O-glucuronide could inhibit Matrix Metalloproteinases ( MMP ) activities, with IC 50 s of 17.63, 7.99, 11.42, 12.85, 0.03 μM for MMP-1 , MMP-3 , MMP-8 , MMP-9 , MMP-13 , respectively.

Application

Products | Products > Disease Areas > Pulmonary Disease | Products > Disease Areas > Autoimmune Disease | Products > Disease Areas > Arthritis | Products > Disease Areas > Pancreatic Cancer | Products > Disease Areas > Digestive System Cancer | Products > Disease Areas > Pain | Products > Disease Areas > Lung Fibrosis | Products > Disease Areas > Rheumatoid Arthritis | Products > Disease Areas > Cancer | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Disease Areas > Inflammation or Immune System Disease | Products > Disease Areas > Respiratory Disease | Products > Disease Areas > Digestive System Disease | Products > Disease Areas > Musculoskeletal and Skin Disease | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Neurological Disease | Products > Research Areas > Inflammation/Immunology | Products > Signaling Pathways > MMP

Product Information

• Catalog No.: HY-N1463
• CAS No.: 29741-10-4
• Molecular Formula: C21H18O12
• Molecular Weight: 462.36
• Purity: 99.98%
• Storage: 4°C, protect from light * In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)
• Solubility: ≥ 2.08 mg/mL (4.50 mM); Clear solution
• Availability: In-stock

Source

Original product source